Stock screener

AMRX

Conviction 100HealthcareScan · Mon, Aug 10, 2026
AMRX$17.86-1.54%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Amneal Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.amneal.com ↗
Price17.86
Change-1.54%
Gap-0.85%
Rel volume2.50×
Avg volume1.97M
Avg $ vol35.62M
SMA 2018.08
SMA 5016.74
SMA 20013.73
Price vs 50+6.66%
Price vs 200+30.06%
MA stackbullish
50/200 cross—
Supertrendup · 17.36
RSI (14)52
MACD hist-0.14
MACD crossbear · 6d
Stoch %K / %D20 / 31
ADX (14)19
+DI / −DI21 / 24
RSI divergence—
MACD divergence—
ATR %+3.44%
ADR %3.34%
52w high19.10
52w low8.54
From 52w high-6.49%
Above 52w low+109.13%
New 52w highNo
SqueezeOff
Bollinger width12.05%
%B0.40
Donchian pos47.76%
Donchian high19.26
Donchian low16.58
AVWAP (52w high)18.38
vs AVWAP high-2.83%
AVWAP (52w low)13.20
vs AVWAP low+35.26%
OBV trendFlat
Chaikin MF (20)0.08
Today vs 20d2.50×
Avg vol (14d)2M
Avg vol (20d)1.97M
Avg $ vol (20d)35.62M
Market cap5.7B
RS 3m (vs SPY)+26.52%
RS 6m (vs SPY)+8.70%
RS line new highNo
Trend template8/8
Technical rank77.5
1 week-5.25%
1 month+5.00%
3 months+35.30%
6 months+23.00%
1 year+117.54%
YTD+41.07%
P/E79.15
P/B172.71
P/S1.89
P/FCF21.13
EPS0.2200
Div yield—
ROE218.20%
ROA1.91%
Debt/Eq77.83
Current2.20
EV/EBITDA—
Gross margin36.88%
Net margin2.39%
Rev growth8.05%
EPS growth161.65%
Price target19.75
Target upside10.58%
Analyst ratingBuy
Institutional57.62%
Ent. value8.15B
Revenue796.2M
Net income57.66M
Gross profit334.51M
Free cash flow269.93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out319.02M
Employees8.5K
ListedMon, May 7, 2018
Free float169.55M
Float %53.2%
Short interest8.12M
Days to cover4.5d
Short volume64.6%
Squeeze score63 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.27 vs $0.24
Last surprise+12.5% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank77.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance19.21
Support16.09
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AMRX

All disclosures →
No recent disclosed trades by Congress in AMRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AMRX · 4 buys · 6 sells

InsiderSideShares
Autor Deborah M.
Director · Class A Common Stock · 2026-05-11
Sell34.82K
Nark Ted C
Director · Class A Common Stock · 2026-05-07
Exercise34.82K
BUCHI J KEVIN
Director · Class A Common Stock · 2026-05-07
Exercise34.82K
George Jeffrey P.
Director · Class A Common Stock · 2026-05-07
Exercise34.82K
MEISTER PAUL M
Director · Restricted Stock Units · 2026-05-07
Exercise48.75K
Yanai Shlomo
Director · Restricted Stock Units · 2026-05-07
Exercise34.82K
Kiely John
Director · Restricted Stock Units · 2026-05-07
Exercise34.82K
Autor Deborah M.
Director · Restricted Stock Units · 2026-05-07
Exercise34.82K
Patel Gautam
Director · Restricted Stock Units · 2026-05-07
Exercise34.82K
Autor Deborah M.
Director · Class A Common Stock · 2026-05-07
Exercise34.82K

SEC filings

EDGAR filings in AMRX · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.